Contents

Issue 47 • January 2022

In association with

When is a drug a device?

We explore the regulatory grey area between drugs and devices and what it can mean for manufacturers

IN DEPTH

Tackling telemedicine fraudsters

Comment

Omicron could energise flu testing

Briefing

Industry news

Medical industry briefing

Covid-19 briefing

Comment

Omicron variant could energise flu testing

MicroLabs aims to boost Covid-19 surveillance

IoT will tackle demand on mental health services

In Depth

When is a drug a device?

3D printing in drug manufacturing

Tackling telemedicine fraudsters

ESG in clinical trials: key themes

Winners of our Excellence Awards

In Data

Investment themes to watch

Data analytics hiring on the rise

North America’s big data hiring boom

Markets and indices

Macro-economic data

01/07/2022 10:22:19
  • Home | Tackling telemedicine fraud
  • In this issue
  • Contents
  • Formacoat Company Insight
  • Formacoat
  • Briefing
  • Industry news
  • The medical industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mikron
  • Comment
  • Omicron variant could energise flu testing in 2022
  • MicroLabs aims to boost Covid-19 surveillance
  • IoT will tackle increased demand on mental health services
  • Sandvik Company Insight
  • Sandvik
  • In Depth
  • When is a drug a device?
  • 3D printing in drug manufacturing: unlocking future possibilities
  • Tackling telemedicine fraudsters
  • ESG in clinical trials: key themes
  • Winners of the Medical Device Network 2021 Excellence Awards
  • Smiths Interconnect
  • In Data
  • Medical industry investment themes to watch in 2022
  • Data analytics hiring levels in the medical industry rose in October
  • North America’s medical industry sees big data hiring boom
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Apple Rubber
  • Events
  • Next Issue